IP Library Granted Patent US 7,063,952
Granted Patent B2
US 7,063,952 · App. 09/966,137 · Granted Jun 20, 2006

Masking background flourescence and luminescence in optical analysis of biomedical assays

Assignee: Bayer Healthcare AG
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,063,952
App. No.
09/966,137
Granted
Jun 20, 2006
Kind
B2
Abstract

In a process for the quantitative optical analysis of fluorescently labelled biological cells 5, a cell layer on a transparent support at the bottom 2 of a reaction vessel 1 is in contact with a solution 3 containing the fluorescent dye 4. The sensitivity of analytical detection can be considerably improved if to the fluorescent dye 4 already present in addition a masking dye 9, which absorbs the excitation light 6 for the fluorescent dye 4 and/or its emission light 7, is added to the solution 3 and/or if a separating layer 10 permeable to the solution and absorbing and/or reflecting the excitation light 6 or the emission light 7 is applied to the cell layer at the bottom 2. This process can also be used for improving the sensitivity in the quantitative optical analysis of a luminescent biological cell layer. The separating layer 10 must in this case be composed such that it has a high power of reflection for the luminescent light 11 . Analogously, these process principles can also be used in receptor studies for the masking of the interfering background radiation in the quantitative optical analysis of fluorescently or luminescently labelled reaction components. In this case, a receptor layer 12 at the bottom 2 of a reaction vessel 1 is in contact with a solution (supernatant 3 ) in which a fluorescent or luminescent ligand 13 is dissolved. The sensitivity and accuracy of the analytical detection can be considerably improved here if a masking dye 9 which absorbs the excitation light 6 for the fluorescent dye and/or its emission light or (in the case of luminescent ligands) the luminescent light is added to the supernatant 3. Instead of the masking dye in the solution 3 or optionally as an additional measure, a separating layer 10 permeable to the solution 3 and absorbing and/or reflecting the excitation light 6 and/or the emission light or the luminescent light can be applied to the cell or receptor layer 12 at the bottom 2.

Claims (57)

1. A composition of matter comprising:

a) a reaction vessel having a transparent support at the bottom of said reaction vessel;

b) a coherent layer of fluorescently labeled biological cells applied to the transparent support;

c) a solution comprising a masking dye in the reaction vessel, the masking dye absorbing at least one of:

i) the excitation energy of any fluorescent dye in the solution; and

ii) the emission light of any fluorescent dye in the solution; and

d) optionally a fluorescent dye in the solution.

2. The composition of matter according to claim 1 , wherein the masking dye is water-soluble and has no cytotoxic side effects.

3. A composition of matter comprising:

a) a reaction vessel having a transparent support at the bottom of said reaction vessel;

b) a coherent layer of fluorescently labeled biological cells applied to the transparent support;

c) a separating layer applied to the coherent layer of fluorescently labeled biological cells, the separating layer being permeable to a solution comprising a fluorescent dye, and the separating layer absorbing, reflecting or both absorbing and reflecting at least one of:

i) the excitation energy of the fluorescent dye in the solution; and

ii) the emission light of the fluorescent dye in the solution; and

d) optionally a solution comprising a fluorescent dye in the reaction vessel.

4. The composition of matter according to claim 3 , wherein the separating layer comprises a layer of polymeric latex beads.

5. The composition of matter according to claim 4 , wherein the polymeric latex beads are dyed with a masking dye.

6. The composition of matter according to claim 5 , wherein the masking dye dyed on the polymeric latex beads is water-soluble and has no cytotoxic side effects.

7. A composition of matter comprising:

a) a reaction vessel having a transparent support at the bottom of said reaction vessel;

b) a coherent layer of fluorescently labeled biological cells applied to the transparent support;

c) a solution comprising a masking dye in the reaction vessel, the masking dye absorbing at least one of:

i) the excitation energy of any fluorescent dye in the solution; and

ii) the emission light of any fluorescent dye in the solution; and

d) a separating layer applied to the coherent layer of fluorescently labeled biological cells, the separating layer being permeable to a solution comprising a fluorescent dye, and the separating layer absorbing, reflecting or both absorbing and reflecting at least one of:

i) the excitation energy of the fluorescent dye in the solution; and

ii) the emission light of the fluorescent dye in the solution; and

e) optionally a fluorescent dye in the solution.

8. The composition of matter according to claim 7 , wherein the masking dye is water-soluble and has no cytotoxic side effects.

9. The composition of matter according to claim 7 , wherein the separating layer comprises a layer of polymeric latex beads.

10. The composition of matter according to claim 9 , wherein the polymeric latex beads are dyed with a masking dye.

11. The composition of matter according to claim 10 , wherein the masking dye dyed on the polymeric latex beads is water-soluble and has no cytotoxic side effects.

12. A composition of matter comprising:

a) a reaction vessel having a transparent support at the bottom of said reaction vessel;

b) a layer of receptors specific for a fluorescent or luminescent ligand applied to or deposited on the transparent support; and

c) a solution comprising a masking dye in the reaction vessel, the masking dye masking the fluorescence or luminescence of any unbound fluorescent or luminescent ligand in the solution.

13. The composition of matter according to claim 12 , wherein the masking dye is water-soluble and has no cytotoxic side effects.

14. A composition of matter comprising:

a) a reaction vessel having a transparent support at the bottom of said reaction vessel;

b) a layer of receptors specific for a fluorescent or luminescent ligand applied to or deposited on the transparent support; and

c) a separating layer applied to the layer of receptors specific for a fluorescent or luminescent ligand, the separating layer being permeable to a solution comprising the fluorescent or luminescent ligand, and the separating layer absorbing, reflecting or both absorbing and reflecting at least one of:

i) the excitation energy of any unbound fluorescent or luminescent ligand remaining in the solution comprising the fluorescent or luminescent ligand; and

ii) the fluorescence or luminescence of any unbound fluorescent or luminescent ligand remaining in the solution comprising the fluorescent or luminescent ligand.

15. The composition of matter according to claim 14 , wherein the separating layer comprises a layer of polymeric latex beads.

16. The composition of matter according to claim 15 , wherein the polymeric latex beads are dyed with a masking dye.

17. The composition of matter according to claim 16 , wherein the masking dye dyed on the polymeric latex beads is water-soluble and has no cytotoxic side effects.

18. A composition of matter comprising:

a) a reaction vessel having a transparent support at the bottom of said reaction vessel;

b) a layer of receptors specific for a fluorescent or luminescent ligand applied to or deposited on the transparent support;

c) a solution comprising a masking dye in the reaction vessel, the masking dye masking the fluorescence or luminescence of any unbound fluorescent or luminescent ligand in the solution; and

d) a separating layer applied to the layer of receptors specific for a fluorescent or luminescent ligand, the separating layer being permeable to a solution comprising the fluorescent or luminescent ligand, and the separating layer absorbing, reflecting or both absorbing and reflecting at least one of:

i) the excitation energy of any unbound fluorescent or luminescent ligand remaining in the solution comprising the fluorescent or luminescent ligand; and

ii) the fluorescence or luminescence of any unbound fluorescent or luminescent ligand remaining in the solution comprising the fluorescent or luminescent ligand.

19. The composition of matter according to claim 18 , wherein the masking dye is water-soluble and has no cytotoxic side effects.

20. The composition of matter according to claim 18 , wherein the separating layer comprises a layer of polymeric latex beads.

21. The composition of matter according to claim 20 , wherein the polymeric latex beads are dyed with a masking dye.

22. The composition of matter according to claim 21 , wherein the masking dye dyed on the polymeric latex beads is water-soluble and has no cytotoxic side effects.

Assignments (4)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 15, 2016
From: BAYER PHARMA AKTIENGESELLSCHAFT
To: BAYER INTELLECTUAL PROPERTY GMBH
Reel/Frame 039756/0128 →
A CHANGE OF NAME WAS RECORDED ON AUGUST 28, 2009 AT REEL/FRAME 023148/0924. THE ADDRESS SHOULD ALSO HAVE BEEN CHANGE FROM LEVERKUSEN GERMANY 51368 TO BERLIN, GERMANY 13353 Recorded Sep 13, 2010
From: BAYER SCHERING PHARMA AKTIENGESELLSCHAFT
To: BAYER SCHERING PHARMA AKTIENGESELLSCHAFT
Reel/Frame 024973/0737 →
CHANGE OF NAME Recorded Aug 28, 2009
From: BAYER HEALTHCARE AG
To: BAYER SCHERING PHARMA AKTIENGESELLSCHAFT
Reel/Frame 023148/0924 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 29, 2005
From: BAYER AKTIENGESELLSCHAFT
To: BAYER HEALTHCARE AG
Reel/Frame 016182/0194 →
Priority Claims (1)
DE 196 21 312 · May 28, 1996 · national
Continuity (2)
Division 0919409900
Related Publication 20020015969A1 · Feb 7, 2002